We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $579M
1-Year Est. Return 94.36%
This Fund
S&P 500
This Quarter Est. Return
+4.36%
1 Year Est. Return
+94.36%
3 Year Est. Return
+196.81%
5 Year Est. Return
+210.19%
10 Year Est. Return
–
AUM
$401M
AUM Growth
-$49.1M
Cap. Flow
-$51.9M
Cap. Flow %
-12.95%
Top 10 Hldgs %
77.61%
Holding
82
New
5
Increased
1
Reduced
3
Closed
2

Top Buys

1
IMMX icon
Immix Biopharma
IMMX
+$3.29M
2
CUE icon
Cue Biopharma
CUE
+$2.35M
3
MODD icon
Modular Medical
MODD
+$1.25M
4
IPWR icon
Ideal Power
IPWR
+$1.2M
5
TALK icon
Talkspace
TALK
+$680K

Top Sells

1
BC icon
Brunswick
BC
+$48.4M
2
LIN icon
Linde
LIN
+$11M
3
BLUE
bluebird bio
BLUE
+$1.87M
4
SLGCW
SomaLogic, Inc. Warrant
SLGCW
+$1.68K
5
FAZEW
FaZe Holdings Inc. Warrant
FAZEW
+$323

Sector Composition

1 Healthcare 17.02%
2 Industrials 16.95%
3 Materials 10.55%
4 Consumer Discretionary 10.23%
5 Financials 9.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BLUE
26
DELISTED
bluebird bio
BLUE
$1.33M 0.33%
51,869
-73,131
-59% -$1.87M
MODD icon
27
Modular Medical
MODD
$17.5M
$1.29M 0.32%
+23,333
New +$1.25M
SPY icon
28
State Street SPDR S&P 500 ETF Trust
SPY
$782B
$1.29M 0.32%
2,470
– –
LBTYK icon
29
Liberty Global Class C
LBTYK
$3.52B
$1.23M 0.31%
69,618
– –
IPWR icon
30
Ideal Power
IPWR
$69.3M
$1.18M 0.3%
+133,000
New +$1.2M
PROF
31
Profound Medical
PROF
$246M
$1.14M 0.28%
133,333
– –
MXCT icon
32
MaxCyte
MXCT
$145M
$1.08M 0.27%
250,000
– –
TALK icon
33
Talkspace
TALK
$874M
$893K 0.22%
+250,000
New +$680K
RCAT icon
34
Red Cat Holdings
RCAT
$1.17B
$765K 0.19%
1,000,000
– –
ONDS icon
35
Ondas Inc
ONDS
$3.79B
$752K 0.19%
775,000
– –
LSXMA
36
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$719K 0.18%
24,197
– –
DMAC icon
37
DiaMedica Therapeutics
DMAC
$384M
$616K 0.15%
222,317
– –
LLYVK icon
38
Liberty Live Group Series C
LLYVK
$9.36B
$605K 0.15%
13,802
– –
RTX icon
39
RTX Corp
RTX
$262B
$585K 0.15%
6,000
– –
ICCC icon
40
ImmuCell
ICCC
$101M
$538K 0.13%
101,594
– –
EVOK
41
DELISTED
Evoke Pharma
EVOK
$503K 0.13%
+68,750
New +$584K
LBTYA icon
42
Liberty Global Class A
LBTYA
$3.63B
$389K 0.1%
22,989
– –
PYPL icon
43
PayPal
PYPL
$50B
$355K 0.09%
5,300
– –
CARR icon
44
Carrier Global
CARR
$57.6B
$349K 0.09%
6,000
– –
LHX icon
45
L3Harris
LHX
$53B
$341K 0.09%
1,600
– –
OTIS icon
46
Otis Worldwide
OTIS
$28.8B
$298K 0.07%
3,000
– –
CRIS icon
47
Curis
CRIS
$9.71M
$272K 0.07%
1,250
– –
LLYVA icon
48
Liberty Live Group Series A
LLYVA
$9B
$256K 0.06%
6,047
– –
PHYS icon
49
Sprott Physical Gold
PHYS
$14.3B
$217K 0.05%
12,540
– –
GPCR icon
50
Structure Therapeutics
GPCR
$3.27B
$214K 0.05%
5,000
– –
1
2
3 4

Similar funds

BCM
Bourgeon Capital Management Darien, Connecticut $578M AUM 41.69% 1-Year Est. Return
LRIA
Leonard Rickey Investment Advisors Yakima, Washington $578M AUM 16.23% 1-Year Est. Return
WCCM
Webs Creek Capital Management Dallas, Texas $578M AUM 79.84% 1-Year Est. Return
MIOT
Massachusetts Institute of Technology Cambridge, Massachusetts $577M AUM 8.5% 1-Year Est. Return
AF
Aegis Financial Mc Lean, Virginia $580M AUM 105.74% 1-Year Est. Return
JCP
JB Capital Partners Armonk, New York $581M AUM 46.16% 1-Year Est. Return
GCM
Gibraltar Capital Management Tulsa, Oklahoma $581M AUM 18.65% 1-Year Est. Return
KNW
Kesler Norman & Wride Ogden, Utah $581M AUM 17.6% 1-Year Est. Return

Bleichroeder LP's Q1 2024 Portfolio in Review

As of Q1 2024, Bleichroeder LP held 82 positions worth $401M, down 11% from $450M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Bleichroeder LP withdrew a net $51.9M in Q1 2024, closing 2 positions and reducing 3 holdings. Its most notable exit was SomaLogic, Inc. Warrant, an estimated $1.68K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Materials.

Against the trend, Bleichroeder LP opened a new position in Immix Biopharma worth $2.61M.

  • Bleichroeder LP's largest Q1 2024 buy was Immix Biopharma: 850,000 shares worth $2.61M.
  • Bleichroeder LP added most to Cue Biopharma in Q1 2024, an estimated $2.35M increase.
  • Bleichroeder LP's biggest Q1 2024 reduction was Brunswick, cutting an estimated $48.4M.
  • Bleichroeder LP fully exited SomaLogic, Inc. Warrant in Q1 2024, selling an estimated $1.68K.
  • Bleichroeder LP's ten largest holdings make up 78% of its $401M portfolio in Q1 2024.
  • Bleichroeder LP opened 5 new positions and closed 2 in Q1 2024.
  • Bleichroeder LP's portfolio value fell 11% quarter-over-quarter to $401M.

Based on Bleichroeder LP's 13F filing for Q1 2024, filed 14 May 2024.